Related Experiment Videos
Advancing prostate cancer: treatment options for the urologist.
William T Lowrance1, Sam S Chang
1Department of Urologic Surgery, Vanderbilt University Medical Center, Nashville, TN 37232-2765, USA.
The Urologic Clinics of North America
|April 25, 2006
Summary
For advancing prostate cancer, androgen deprivation therapy has been standard for decades. New treatments offer more options, guiding urologists through complex patient care decisions for better outcomes.
Area of Science:
- Oncology
- Urology
Background:
- Androgen deprivation therapy (ADT) has been the primary treatment for advanced prostate cancer for over 60 years.
- Patient populations with advancing prostate cancer are diverse, complicating treatment decisions.
Observation:
- A case presentation is used to illustrate treatment strategies.
- The study outlines a logical progression of treatment options.
Findings:
- New chemotherapeutic agents are now available.
- Novel hormone manipulations and adjunctive therapies expand treatment possibilities.
Implications:
- Provides a practical guide for urologists managing advanced prostate cancer.
- Highlights the evolving landscape of prostate cancer therapeutics.
- Aims to assist in optimizing patient care through informed treatment selection.